An early pilot trial suggests that combining atezolizumab (tecectriq) with rituximab (Rituxan), gemcitabine (gemzar) and ...
Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate.
The Pullman Fire Department recently participated in a stair climb fundraiser organized by the Leukemia and Lymphoma Society.
The Scotia-Glenville Central School District says their team, “Rays of Hope,” is committed to the Leukemia and Lymphoma ...
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...
Investing.com -- The European Commission has granted Bristol Myers (NYSE: BMY) Squibb, the biopharmaceutical company based in ...
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...
Verywell Health on MSN14d
6 Symptoms of Dying of Lymphoma
Lymphoma causes symptoms of organ failure before death. Learn what patients in palliative or hospice care could experience ...
T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...
By comparing tattoo patterns alongside cancer diagnoses, researchers found that people with tattoos have a higher occurrence ...
Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied ...